logo
Select company
Select metric
$ 94.48MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
8
Sector
12
Industry
17
History
16
$ 2.61Close
$ 1.45 - $ 3.73 52-Week Range
Ticker Information

Ticker

WHWK

Company Name

WHITEHAWK THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

WHITEHAWK THERAPEUTICS INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

WHWK - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 94.48M
3/31/2025$ 95.35M
12/31/2024$ 146K
9/30/2024$ 208K
6/30/2024$ 210K
3/31/2024$ 478K
12/31/2023$ 486K
9/30/2023$ 701K
6/30/2023$ 73.22M
3/31/2023$ 72.99M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • WHITEHAWK THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Equity stands at $ 0.
  • Over the past 5 years, WHITEHAWK THERAPEUTICS INC's average CF - Equity has been $ 55.92M.
  • The median CF - Equity for WHITEHAWK THERAPEUTICS INC during this period was $ 41.24M
  • WHITEHAWK THERAPEUTICS INC reached its highest CF - Equity over the past 5 years at $ 156.16M.
  • The lowest CF - Equity recorded by WHITEHAWK THERAPEUTICS INC in the same timeframe $ 0

WHITEHAWK THERAPEUTICS INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
HYFT : MINDWALK HOLDINGS CORP $ 8.47MIRD : OPUS GENETICS INC $ 22.07MEQ : EQUILLIUM INC $ 148KSRZN : SURROZEN INC $ 71.35MVRCA : VERRICA PHARMACEUTICALS INC $ 39.64MICCC : IMMUCELL CORP $ 4.38MBRNS : BARINTHUS BIOTHERAPEUTICS PLC $ 1.3MSEER : SEER INC $ -15.79MGBIO : GENERATION BIO CO $ 252KMGX : METAGENOMI INC $ -383K

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

WHWK - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 0

Minimum

Sep 30, 2020

$ 156.16M

Maximum

Jun 30, 2022

$ 55.92M

Average

$ 41.24M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 130.54K with a standard deviation of $ 17.65M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 130.54K
median$ 0
std$ 17.65M